Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Arcus Biosciences (RCUS) over the last 4 years, with Dec 2024 value amounting to $90.1 million.

  • Arcus Biosciences' Shares Outstanding (Diluted Average) rose 16.52% to $106.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.5 million, marking a year-over-year increase of 16.52%. This contributed to the annual value of $90.1 million for FY2024, which is 21.76% up from last year.
  • According to the latest figures from FY2024, Arcus Biosciences' Shares Outstanding (Diluted Average) is $90.1 million, which was up 21.76% from $74.0 million recorded in FY2023.
  • In the past 5 years, Arcus Biosciences' Shares Outstanding (Diluted Average) ranged from a high of $90.1 million in FY2024 and a low of $72.0 million during FY2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $74.0 million (2023), whereas its average is $78.7 million.
  • As far as peak fluctuations go, Arcus Biosciences' Shares Outstanding (Diluted Average) decreased by 2.70% in 2022, and later increased by 21.76% in 2024.
  • Yearly analysis of 4 years shows Arcus Biosciences' Shares Outstanding (Diluted Average) stood at $74.0 million in 2021, then declined by 2.70% to $72.0 million in 2022, then grew by 2.78% to $74.0 million in 2023, then increased by 21.76% to $90.1 million in 2024.